A critical advance in cancer investigation is occurring with the use of mini-antibodies to reactivate damaged p53. This vital malignant suppressor protein is frequently disabled in several forms of tumors, causing https://e-bookmarks.com/story7742483/mini-antibodies-reactivate-the-p53-protein-a-new-approach-for-cancer-management